EquitiesMedium impact
ADXN Looks 594.6% Overvalued on GF Value™
gurufocus.com·5 days ago·Global·1 min read
Rigense market context
Equities
No image available. Showing a neutral Rigense placeholder.
On August 26, 2026, Addex Therapeutics Ltd (NASDAQ: ADXN) announced a successful At-the-Market (ATM) offering, raising $2.8 million (CHF 2.2 million) by selling
Related news
Equities
PRTH Looks 7.3% Undervalued on GF Value™
gurufocus.com
Equities
AeroVironment wins $51M U.S. Army Switchblade 600 order (NASDAQ:AVAV)
seekingalpha.com
Equities
Better and Coinbase launch token-backed, conforming mortgage (BETR:NASDAQ)
seekingalpha.com
Equities
Abercrombie & Fitch Co. 2026 Q2 - Results - Earnings Call Presentation (NYSE:ANF) 2026-08-26
seekingalpha.com
Equities
Spyre Therapeutics (SYRE) Plummets 14.3% Pre-Market Amid Market Caution
gurufocus.com
Equities
Cathie Wood Isn't Backing Away From SpaceX Stock
gurufocus.com